C. Pau

发表

Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.

S. Osmanov, J. Weber, G. Schochetman, 1998, AIDS research and human retroviruses.

Presentation of HIV V3 loop epitopes for enhanced antigenicity, immunogenicity and diagnostic potential

S. Zolla-Pazner, M. Gorny, D. Birx, 1995, AIDS.

The epidemiological evolution of HIV-1 subtypes B and E among heterosexuals and injecting drug users in Thailand, 1992-1997.

T. Mastro, K. Limpakarnjanarat, N. Young, 1998, AIDS.

HIV-1 subtypes and male-to-female transmission in Thailand

P. Phanuphak, S. Rerks-Ngarm, J. Kreiss, 1995, The Lancet.

Oral fluid as a specimen for detection and confirmation of antibodies to human immunodeficiency virus type 1

T. Granade, J. R. George, B. Parekh, 1995, Clinical and diagnostic laboratory immunology.

Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization.

M. Kalish, G. Schochetman, J. R. George, 1994, AIDS research and human retroviruses.

Oligomeric nature of transmembrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis.

H. Gayle, K. D. de Cock, G. Schochetman, 1991, AIDS.

Frequency of human immunodeficiency virus (HIV) infection among contemporary anti‐HIV‐1 and anti‐HIV‐½ supplemental test‐ indeterminate blood donors

A. Williams, G. B. Schreiber, H. Ownby, 1996, Transfusion.

The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention.

D J Hu, B G Weniger, C. Luo, 1996, JAMA.

Factors influencing HIV-1 banding patterns in miniaturized western blot testing of dried blood spot specimens.

M. Gwinn, W. H. Hannon, G. Schochetman, 1992, Journal of immunological methods.

Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins.

J. Gatewood, J. Fontenot, S. Mariappan, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.

N. Shaffer, P. Thomas, G. Schochetman, 1991, AIDS (London).

Evaluation of testing algorithms following the use of combination HIV-1/HIV-2 EIA for screening purposes.

I. Onorato, G. Schochetman, C. Schable, 1993, AIDS research and human retroviruses.

Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections

H. Jaffe, G. Schochetman, L. Zekeng, 1994, The Lancet.

Surveillance for human immunodeficiency virus type 1 group O infections in the United States

F. McCutchan, M. Busch, A. Brown, 1996, Transfusion.

Simian immunodeficiency virus needlestick accident in a laboratory worker

W. Heneine, R. Khabbaz, T. Rowe, 1992, The Lancet.

Track C Epidemiology and Prevention Science

David R. Holtgrave, W. Heneine, Y. Nakamura, 2012, Journal of the International AIDS Society.

Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades.

C. Luo, E. Abrams, P. Palumbo, 2001, The Journal of infectious diseases.

Distribution of HIV‐1 Subtypes Among HIV‐Seropositive Patients in the Interior of Côte d'Ivoire

C. Luo, D. Pieniążek, J. Nkengasong, 2000, Journal of acquired immune deficiency syndromes.

Misidentification of HIV-2 proteins by western blots

H. Gayle, G. Schochetman, K. Decock, 1991, The Lancet.